handelnine global llcdrugHigh PriorityActive

Rheumacare Manufacturing Recall

Rheumacare capsules, , Mfg in India by: Virgo UAP Pharma has been recalled due to cgmp deviations: product found to contain lead.. Patients taking this medication should consult their pharmacist or doctor.

By RecallRadar Editorial Team

Sourced from FDA. Last verified March 4, 2026.

On this page

Free checker

Check if you qualify

See whether your device may qualify for a free repair or replacement program before you spend money.

Check if you qualify

Key facts

Date announced: December 22, 2025
Source agency: FDA

This recall involves safety concerns. Take action promptly.

✨ Plain-English Summary

Is This Recall Still Active?

Status: Yes - Active

This recall is currently active. If your device matches the affected models, follow the official instructions as soon as possible.

What's Being Recalled

Quoted source excerpt from the official notice.

CGMP Deviations: product found to contain lead.

Quick Info

Key facts from the official notice, kept in the article flow for easy cross-checking.

Brand: Handelnine global llc
Category: drug
Source agency: FDA
Announced: December 22, 2025
Country: US
Status: Active

Who's Affected

Specific models and identifiers listed in the source notice:

Model #1

Lot: CAM040, Exp. 06/30/2029 Lot: CAL079-N, Exp. 09/30/2028

#	Model
1	Lot: CAM040, Exp. 06/30/2029 Lot: CAL079-N, Exp. 09/30/2028

Technical model codes are manufacturer identifiers. Match both the product name and model code from your device settings, label, or packaging.

What You Should Do

Follow the remedy path from the official notice using the exact model and serial details above.

1## Rheumacare capsules, 30 count bottle, Mfg in India by: Virgo UAP Pharma Pvt. Ltd., Ahmedabad, India UPC 8 904218 700313 Agency: FDA | Category: drug Reason: CGMP Deviations: product found to contain lead. What to do:
2Stop using the product if your lot/model matches.
3Check the FDA notice for specifics.
4Follow remedy instructions.

Open Official Recall Notice

Source & Verification

This page summarizes the official notice and keeps key facts easy to verify.

Official source: FDA
Announced by source: December 22, 2025
Last reviewed by RecallRadar: March 4, 2026

Frequently Asked Questions

Am I affected by this recall?

Check the affected models section on this page. The official notice currently lists Lot: CAM040, Exp. 06/30/2029 Lot: CAL079-N, Exp. 09/30/2028.

What is the remedy for this recall?

## Rheumacare capsules, 30 count bottle, Mfg in India by: Virgo UAP Pharma Pvt. Ltd., Ahmedabad, India UPC 8 904218 700313 Agency: FDA | Category: drug Reason: CGMP Deviations: product found to contain lead. What to do: 1. Stop using the product if your lot/model matches. 2. Check the FDA notice for specifics. 3. Follow remedy instructions.

Where can I verify recall details?

Use the official source link in this page to confirm dates, eligibility, and next steps: https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts

Keep browsing with these internal hubs: handelnine global llc recall hub and Food & Drug recall hub.